1. Home
  2. ABX vs DNA Comparison

ABX vs DNA Comparison

Compare ABX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abacus Global Management Inc. Class A Common Stock

ABX

Abacus Global Management Inc. Class A Common Stock

N/A

Current Price

$9.68

Market Cap

725.3M

Sector

Finance

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$6.47

Market Cap

607.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABX
DNA
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
725.3M
607.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABX
DNA
Price
$9.68
$6.47
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
567.7K
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$97.36
$1.60
Revenue Next Year
$13.66
N/A
P/E Ratio
$74.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.18
$5.00
52 Week High
$10.03
$17.58

Technical Indicators

Market Signals
Indicator
ABX
DNA
Relative Strength Index (RSI) 66.19 34.28
Support Level $8.10 N/A
Resistance Level N/A $10.05
Average True Range (ATR) 0.39 0.59
MACD 0.11 -0.26
Stochastic Oscillator 80.45 2.06

Price Performance

Historical Comparison
ABX
DNA

About ABX Abacus Global Management Inc. Class A Common Stock

Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: